Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-24 @ 8:02 PM
Ignite Modification Date:
2025-12-24 @ 8:02 PM
NCT ID:
NCT00004204
Brief Title:
Temozolomide in Treating Patients With Recurrent or Progressive Malignant Glioma
Official Title:
A Phase II Study of Temozolomide in the Treatment of Recurrent Malignant Gliomas
Study:
NCT00004204
Protocol Section:
NCT00004204